Skip to main content
British Journal of Pharmacology and Chemotherapy logoLink to British Journal of Pharmacology and Chemotherapy
. 1965 Oct;25(2):442–455. doi: 10.1111/j.1476-5381.1965.tb02063.x

Activity of centrally acting and other drugs against tremor and hypothermia induced in mice by tremorine.

P S Spencer
PMCID: PMC1510744  PMID: 5866724

Full text

PDF
446

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. AHMED A., MARSHALL P. B. Relationship between anti-acetylcholine and anti-Tremorine activity in anti-parkinsonian and related drugs. Br J Pharmacol Chemother. 1962 Apr;18:247–254. doi: 10.1111/j.1476-5381.1962.tb01405.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. BENESOVA O., TRINEROVA I. THE EFFECTS OF PSYCHOTROPIC DRUGS ON THE CHOLINERGIC AND ADRENERGIC SYSTEM. Int J Neuropharmacol. 1964 Oct;3:473–478. doi: 10.1016/0028-3908(64)90031-0. [DOI] [PubMed] [Google Scholar]
  3. BRITTAIN R. T., JACK D., SPENCER P. S. MECHANISM OF ACTION OF MONOAMINE OXIDASE INHIBITORS IN ENHANCING AMPHETAMINE TOXICITY. J Pharm Pharmacol. 1964 Aug;16:565–567. doi: 10.1111/j.2042-7158.1964.tb07515.x. [DOI] [PubMed] [Google Scholar]
  4. BRITTAIN R. T., SPENCER P. S. MEASUREMENT OF BODY TEMPERATURE IN CONSCIOUS SMALL LABORATORY ANIMALS BY MEANS OF AN OESOPHAGEAL THERMOCOUPLE. J Pharm Pharmacol. 1964 Jul;16:497–499. doi: 10.1111/j.2042-7158.1964.tb07501.x. [DOI] [PubMed] [Google Scholar]
  5. BUCKETT W. R., HAINING C. G. SOME PHARMACOLOGICAL STUDIES ON THE OPTICALLY ACTIVE ISOMERS OF HYOSCINE AND HYOSCYAMINE. Br J Pharmacol Chemother. 1965 Feb;24:138–146. doi: 10.1111/j.1476-5381.1965.tb02088.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. CHO A. K., HASLETT W. L., JENDEN D. J. The identification of an active metabolite of tremorine. Biochem Biophys Res Commun. 1961 Jul 26;5:276–279. doi: 10.1016/0006-291x(61)90162-0. [DOI] [PubMed] [Google Scholar]
  7. COSTA E., GARATTINI S., VALZELLI L. Interactions between reserpine, chlorpromazine, and imipramine. Experientia. 1960 Oct 15;16:461–463. doi: 10.1007/BF02171155. [DOI] [PubMed] [Google Scholar]
  8. DOMENJOZ R., THEOBALD W. [On the pharmacology of tofranil (N-(3-dimethylaminopropyl)-iminodibenzyl hydrochloride]. Arch Int Pharmacodyn Ther. 1959 Jul 1;120:450–489. [PubMed] [Google Scholar]
  9. EVERETT G. M., BLOCKUS L. E., SHEPPERD I. M. Tremor induced by tremorine and its antagonism by anti-Parkinson drugs. Science. 1956 Jul 13;124(3211):79–79. doi: 10.1126/science.124.3211.79. [DOI] [PubMed] [Google Scholar]
  10. EVERETT G. M. Tremor produced by drugs. Nature. 1956 Jun 30;177(4522):1238–1238. doi: 10.1038/1771238a0. [DOI] [PubMed] [Google Scholar]
  11. FARQUHARSON M. E., JOHNSTON R. G. Antagonism of the effects of tremorine by tropine derivatives. Br J Pharmacol Chemother. 1959 Dec;14:559–566. doi: 10.1111/j.1476-5381.1959.tb00964.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. FINK M. Electroencephalographic and behavioral effects of tofranil. Can Psychiatr Assoc J. 1959;4(Suppl):166–171. doi: 10.1177/070674375900401s17. [DOI] [PubMed] [Google Scholar]
  13. FROMMEL E., GAILLAND L. A., FLEURY C. [The pharmacodynamics of antiparkinsonian substances]. Schweiz Arch Neurol Neurochir Psychiatr. 1959;84:97–109. [PubMed] [Google Scholar]
  14. FROMMEL E. La pharmacodynamie de la médication antiparkinsonienne. Presse Med. 1958 Nov 8;66(78):1745–1746. [PubMed] [Google Scholar]
  15. GEORGE R., HASLETT W. L., JENDEN D. J. The central action of a metabolite of tremorine. Life Sci. 1962 Aug;1:361–363. doi: 10.1016/0024-3205(62)90060-7. [DOI] [PubMed] [Google Scholar]
  16. HALLIWELL G., QUINTON R. M., WILLIAMS F. E. A COMPARISON OF IMIPRAMINE, CHLORPROMAZINE AND RELATED DRUGS IN VARIOUS TESTS INVOLVING AUTONOMIC FUNCTIONS AND ANTAGONISM OF RESERPINE. Br J Pharmacol Chemother. 1964 Oct;23:330–350. doi: 10.1111/j.1476-5381.1964.tb01590.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. KERANEN G. M., ZARATZIAN V. L., COLEMAN R. Studies on 1,4-dipyrrolidino-2-butyne (Tremorine) in mice. Toxicol Appl Pharmacol. 1961 Jul;3:481–492. doi: 10.1016/0041-008x(61)90064-3. [DOI] [PubMed] [Google Scholar]
  18. LESLIE G. B., MAXWELL D. R. INHIBITION OF TREMORINE BY A GROUP OF NON-ANTI-PARKINSON PHENOTHIAZINE DERIVATIVES. Nature. 1964 Apr 4;202:97–98. doi: 10.1038/202097a0. [DOI] [PubMed] [Google Scholar]
  19. METYSOVA J., METYS J., VOTAVA Z. PHARMAKOLOGISCHE EIGENSCHAFTEN EINIGER NEUEN TRANQUILIZERS UND ANTIDEPRESSIVEM SUBSTANZEN. Arch Int Pharmacodyn Ther. 1963 Aug 2;144:481–513. [PubMed] [Google Scholar]
  20. PATTEN B. M., SAKAMOTO A., VANWOERT M. H., PAPAVASILIOU P. S., COTZIAS G. C. TREMORINE-INDUCED TREMOR VERSUS EXTRAPYRAMIDAL DISEASE. Nature. 1964 Feb 29;201:929–930. doi: 10.1038/201929a0. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology and Chemotherapy are provided here courtesy of The British Pharmacological Society

RESOURCES